Literature DB >> 8324129

Empyema due to Bacteroides gracilis: case report and in vitro susceptibilities to eight antimicrobial agents.

D Lee1, E J Goldstein, D M Citron, S Ross.   

Abstract

We describe a patient with empyema due to Bacteroides gracilis and a viridans streptococcus. Therapy with both cefoxitin and imipenem failed, and the patient remained symptomatic even after thoracotomy was performed. Clinical response occurred after initiation of clindamycin therapy. The susceptibilities of the patient's isolate, other clinical strains, and the reference strain were determined by an agar dilution method. The isolates were generally susceptible to all the agents tested; however, some strains were resistant to clindamycin (MIC, 8 micrograms/mL), penicillin G (MIC90, 16 micrograms/mL), and metronidazole (MIC90, 64 micrograms/mL). The B. gracilis isolate from our patient was susceptible to all agents tested, including cefoxitin and imipenem.

Entities:  

Mesh:

Year:  1993        PMID: 8324129     DOI: 10.1093/clinids/16.supplement_4.s263

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

Review 1.  Pathogenomics of Emerging Campylobacter Species.

Authors:  Daniela Costa; Gregorio Iraola
Journal:  Clin Microbiol Rev       Date:  2019-07-03       Impact factor: 26.132

2.  Fatal bacteremia caused by Campylobacter gracilis, United States.

Authors:  Takashi Shinha
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.